Sanofi un­veils $476M vac­cine plant in Sin­ga­pore, bring­ing its to­tal out­lay to $1.7B in the field for past year

Sanofi is ready to spend mon­ey on man­u­fac­tur­ing to pre­pare for the next glob­al pan­dem­ic, and they aren’t be­ing shy about it. In the lat­est in a flur­ry of moves, the French drug­mak­er an­nounced it will in­vest €400 mil­lion — rough­ly $476.26 mil­lion — at a new site in Sin­ga­pore.

The move, an­nounced Mon­day, will help com­ple­ment Sanofi’s ex­ist­ing man­u­fac­tur­ing fa­cil­i­ties in Eu­rope and North Amer­i­ca, and will help re­spond quick­ly to pan­dem­ic risks in the fu­ture. The project is ex­pect­ed to cre­ate up to 200 lo­cal jobs and up Sin­ga­pore’s sta­tus as a home to in­no­va­tion in the health­care in­dus­try. EVP Thomas Tri­om­phe said:

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER